Biotechnology Services Market by Service Type (Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services), End-Users (Biotechnology Companies, Clinical Research Organizations(CROs), Contract Manufacturers Organizations (CMOs)) - Global F

Biotechnology Services Market by Service Type (Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services), End-Users (Biotechnology Companies, Clinical Research Organizations(CROs), Contract Manufacturers Organizations (CMOs)) - Global Forecast 2024-2030


The Biotechnology Services Market size was estimated at USD 193.05 billion in 2023 and expected to reach USD 214.69 billion in 2024, at a CAGR 11.60% to reach USD 416.25 billion by 2030.

Global Biotechnology Services Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biotechnology Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biotechnology Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage



This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Service Type
Cell Processing & Isolation
Donor Recruitment
Food Biotechnology Services
Prevention & Disease Control
Public Engagement Activities
Tissue Collection
End-Users
Biotechnology Companies
Clinical Research Organizations(CROs)
Contract Manufacturers Organizations (CMOs)
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biotechnology Services Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biotechnology Services Market?
3. What are the technology trends and regulatory frameworks in the Biotechnology Services Market?
4. What is the market share of the leading vendors in the Biotechnology Services Market?
5. Which modes and strategic moves are suitable for entering the Biotechnology Services Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biotechnology Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
5.1.1.2. Growing rate of academic research activities and need for efficient facilities
5.1.1.3. Rising expansion of contract research and manufacturing services
5.1.2. Restraints
5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
5.1.3. Opportunities
5.1.3.1. Advancements in biotechnology instruments and techniques
5.1.3.2. Emerging funding and investment activities in biotechnology research
5.1.4. Challenges
5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biotechnology Services Market, by Service Type
6.1. Introduction
6.2. Cell Processing & Isolation
6.3. Donor Recruitment
6.4. Food Biotechnology Services
6.5. Prevention & Disease Control
6.6. Public Engagement Activities
6.7. Tissue Collection
7. Biotechnology Services Market, by End-Users
7.1. Introduction
7.2. Biotechnology Companies
7.3. Clinical Research Organizations(CROs)
7.4. Contract Manufacturers Organizations (CMOs)
8. Americas Biotechnology Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biotechnology Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biotechnology Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Agilent Technologies, Inc.
12.1.2. Almac Group Limited
12.1.3. AnaBioTec NV
12.1.4. Avance Clinical Pty Ltd.
12.1.5. Azenta Life Sciences
12.1.6. Becton, Dickinson and Company
12.1.7. Biogen Inc.
12.1.8. BioIVT LLC
12.1.9. Caidya
12.1.10. Catalent, Inc.
12.1.11. Charles River Laboratories International, Inc.
12.1.12. CMIC Group
12.1.13. Contract Pharmacal Corp.
12.1.14. Crown Bioscience, Inc.
12.1.15. Danaher Corporation
12.1.16. Eurofins Scientific Limited
12.1.17. GE HealthCare Technologies Inc.
12.1.18. GenScript Biotech Corporation
12.1.19. ICON PLC
12.1.20. ITR Laboratories Canada
12.1.21. Kaneka Corporation
12.1.22. Laboratory Corporation of America Holdings
12.1.23. Merck KGaA
12.1.24. Novartis AG
12.1.25. Siemens Healthcare GmbH
12.1.26. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. BIOTECHNOLOGY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. BIOTECHNOLOGY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOTECHNOLOGY SERVICES MARKET DYNAMICS
FIGURE 7. BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 8. BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 10. BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings